Hormone therapy in climactere and postmenopausal woman. A consensus of the DGGG;Konsensusempfehlungen zur hormontherapie (HT) im klimakterium und in der postmenopause: Im auftrag des vorstands der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe

Geburtshilfe und Frauenheilkunde

Volumn 63, Issue 3, 2003, Pages 209-212

  Beckmann, M W ^b   Braendle, W ^b   Brucker, C ^b   Doren M ^b   Emons, G ^b   Gelsthovel F ^b   Kiesel, L ^b   Konig K ^b   Nass Griegoleit I ^b   Ortmann, Olaf ^a   Rabe, T ^b   Windler, E ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

ALZHEIMER DISEASE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLORECTAL CARCINOMA; DYSPAREUNIA; ENDOMETRIUM CARCINOMA; EPIDEMIOLOGICAL DATA; HORMONAL THERAPY; HUMAN; MEDICAL SOCIETY; MENOPAUSAL SYNDROME; META ANALYSIS; MONOTHERAPY; OSTEOPOROSIS; OVARY CARCINOMA; POSTMENOPAUSE; PRACTICE GUIDELINE; REVIEW; THROMBOEMBOLISM; VAGINA ATROPHY;

EID: 0037357527     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38433     Document Type: Review

References (19)

1. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 942-944
2. Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B, Heart and Estrogen/Progestin Replacement Study Research Group. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001; 98: 1045-1052
3. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 1998; 92: 722-727
4. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T, the HERS Research Group. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001; 97: 116-120
5. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-313
6. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57
7. Grimes DA, Lobo RA. Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet Gynecol 2002; 100: 1344-1353
8. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-613
9. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W et al. for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 2002; 288: 58-66
10. Humphrey LL, Chan BKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Int Med 2002; 137: 273-284
11. Lacey JV, Mink PJ, Lubin JI, Sherman ME, Troisi R, Hartge P et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288: 334-341
12. Lethaby A, Farquhar S, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding (Cochrane Review). Cochrane Database Syst Rev 2000 (2); CD 000,402
13. MacLennan A, Lester S, Moore V et al. Oral replacement therapy versus placebo for hot flushes. (Cochrane Review). Cochrane Database Syst Rev 2001 (1); CD 002978
14. MacLennan A, Lester S, Moore V et al. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 2001; 4: 58-74
15. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy. JAMA 2002; 288: 872-881
16. Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 2001; 285: 1460-1465
17. The ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 2002; 360: 2001-2008
18. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Controlled Clinical Trials 1998; 19: 61-109
19. Writing Group for the Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321-333